1. ECOG Agenda, November 2004, pp 605–672. Available at www.ecog.org
2. Induction chemotherapy followed by standard thoracic radiotherapy (std, TRT) vs. hyperfractionated accelerated radiotherapy (HART) for patients with unresectable stage IIIA and B non-small cell lung cancer (NSCLC);Belani;Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597). Proc Am Soc Clin Oncol,2003
3. RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small cell lung cancer;Bepler;J Clin Oncol,2004
4. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer;Lord;Clin Cancer Res,2002